on MIG CAPITAL AG
MIG Capital Overcomes Market Challenges in 2025
In 2025, MIG Capital AG navigated a difficult market, investing €32 million in deep tech and life sciences firms. This investment, in collaboration with co-investors, brought the total to €514 million for the year. Significant investments included startups CoreMedic, ASTRA, and NcodiN. CoreMedic, focusing on cardiology, raised funds for a study in February, while ASTRA secured seed funding in July for animal health precision medicines. In November, French startup NcodiN received €16 million for AI hardware development.
Notable achievements included IQM's USD 320 million financing round and Look Up's €50 million for space safety technologies. High-impact partnerships boosted AMSilk's industrial spider silk production. MIG also divested several firms, distributing €8.5 million to investors.
Looking ahead, Dr. Matthias Kromayer sees execution, scaling, and visibility as key challenges for 2026. MIG Capital plans to leverage its expertise to foster technological growth in Germany and Europe, continuing its focus on deep tech and life sciences innovation.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all MIG CAPITAL AG news